Finance

Lists
Why is 301281 down 3.24%?
Dive Deeper
301281:SHE
Shandong Keyuan Pharmaceutical Co Ltd
CNÂ¥45.72
-3.24%
(-1.53) 1D
Oct 8, 3:04:34 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301281...
Open
CNÂ¥47.72
High
CNÂ¥49.50
Low
CNÂ¥44.80
Mkt. cap
5.12B
Avg. vol.
2.56M
Volume
2.72M
Dividend
0.11%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 16, 2026
P/E ratio
128.39
52-wk high
CNÂ¥59.24
52-wk low
CNÂ¥25.87
EPS
CNÂ¥0.36
Shares outstanding
108.29M
No. of employees
650
Open
CNÂ¥47.72
High
CNÂ¥49.50
Low
CNÂ¥44.80
Mkt. cap
5.12B
Avg. vol.
2.56M
Volume
2.72M
Dividend
0.11%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 16, 2026
P/E ratio
128.39
52-wk high
CNÂ¥59.24
52-wk low
CNÂ¥25.87
EPS
CNÂ¥0.36
Shares outstanding
108.29M
No. of employees
650
News stories
From web sources and news partners
About Shandong Keyuan Pharmaceutical Co Ltd
CEO-
Employees650
FoundedDec 27, 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
74.82M
95.54M
161.30M
170.16M
Cost of goods sold
39.09M
56.86M
68.39M
82.50M
Cost of revenue
39.09M
56.86M
68.39M
82.50M
Research and development expenses
16.13M
6.86M
5.72M
5.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.69M
35.57M
52.40M
46.74M
Operating expense
40.99M
47.71M
60.30M
57.17M
Total operating expenses
80.08M
104.56M
128.70M
139.67M
Operating income
-5.25M
-9.02M
32.61M
30.49M
Other non operating income
4.39M
-4.31M
-335.82K
281.10K
EBT including unusual items
-11.82M
-15.17M
32.69M
39.96M
EBT excluding unusual items
-566.63K
-11.60M
33.02M
29.87M
Income tax expense
-439.44K
-281.98K
2.16M
6.03M
Effective tax rate
3.72%
1.86%
6.60%
15.08%
Other operating expenses
-3.05M
4.13M
-1.44M
4.47M
Net income
-11.21M
-14.92M
30.07M
34.62M
Net profit margin
-14.99%
-15.61%
18.64%
20.34%
Earnings per share
-
-
-
-
Interest and investment income
814.75K
1.69M
805.04K
237.97K
Interest expense
-
-
-59.45K
-398.62K
Net interest expenses
814.75K
1.69M
745.59K
-160.66K
Depreciation and amortization charges
-
-
-
-
EBITDA
5.57M
2.89M
44.52M
42.48M
Gain or loss from assets sale
-
-303.64K
-
-
AI content may include mistakes. Learn more
Google apps